The SEC is hurting American Marijuana Companies

Canada's coined the name "Land of Opportunity" for its immigration friendly policies and entrepreneurial spirit, and US pot companies are definitely capitalizing on that reputation.

Companies that are operating in states where marijuana is legal, are not able to get listed on US stock exchanges due to the SEC's rules on the types of companies that can be listed. Marijuana is still considered an illegal drug by the US federal government, and therefore companies that deal with it are not allowed to trade on American stock exchanges.

Several companies are jumping ship and getting listed in Canada. Primarily on the two public venture capital exchanges, the TSX Venture Exchange (TSXV) and the Canadian Securities Exchange (CSE).

Green Thumb Industries (GTII) is the most recent converter. Raising $67 million USD in their initial public offering on the Canadian Securities Exchange.

I think this is going to hurt the US cannabis industry long-term, since due to current regulations, companies are moving north, even though their main operations are in the United States.

What can be done here, short of legalizing marijuana entirely, to entice companies to remain in the US?

 
Most Helpful

Reiciendis incidunt architecto aut dolores hic consequatur. Accusantium voluptas neque dignissimos voluptatibus incidunt. Voluptatem laborum quas eveniet veniam error.

Created a 1-step skincare solution for men. Purchase + reviews appreciated: www.w34th.com

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (87) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”